NCT05926596

Brief Summary

The purpose of this research study is to develop a protocol using a fully wearable, portable lower-limb exoskeleton for improving leg and walking function in people with movement disorders. The study investigates the effects of wearing the device during a set of experiments including leg stretching, treadmill walking and overground walking in muscle activity, joint motion, and gait performance. The goal is to develop an effective lower-limb strategy to restore lost leg function (e.g., range of motion) and gait ability, and improve quality of life in people with movement deficits following a neurological disorder.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Feb 2026Oct 2026

First Submitted

Initial submission to the registry

June 22, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 3, 2023

Completed
2.6 years until next milestone

Study Start

First participant enrolled

February 9, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

February 23, 2026

Status Verified

February 1, 2026

Enrollment Period

8 months

First QC Date

June 22, 2023

Last Update Submit

February 19, 2026

Conditions

Keywords

exoskeletonspasticity

Outcome Measures

Primary Outcomes (3)

  • 3D postures

    3D postures will be assessed using the device, combining measurements of multiple joints in space

    Through study completion, an average of 24 weeks

  • Joint angles

    Hip and knee joint angles measured in degrees will be assessed using the device

    Through study completion, an average of 24 weeks

  • Joint angular velocities

    Hip and knee joint velocities measured in radians per second or degrees per second will be assessed using the device

    Through study completion, an average of 24 weeks

Study Arms (1)

Robotic Exoskeleton

EXPERIMENTAL

All participants will be interfered with a wearable robotic exoskeleton.

Device: Wearable Robotic Exoskeleton

Interventions

* Participant preparation, placement of wearable sensors and monitoring, and wearable device fitting. * Lower-limb joint rotations and leg stretching protocol (40-60 minutes). The wearable exoskeleton and its control algorithm are evaluated to rotate leg joints and apply stretching similarly to the forces applied by nurses and caregivers when providing manual forces. Joint rotation and limb stretching is conducted while participants sit down (e.g., in a wheelchair, on a chair, on one side of a bed, or on a clinical mat) or lay down on a bed/mat. The protocol involves ankle plantarflexion and dorsiflexion, knee extension, hip flexion with the knee flexed, and toe flexion and extension (bilaterally) assisted by the exoskeleton, and each movement is repeated at a low-to-moderate rate of 10-30 cycles/minute. * Treadmilll and Overground Walking (60-90 minutes including rest periods) * Cool down (5-10 minutes)

Robotic Exoskeleton

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran individuals with spasticity due to spinal cord injury (SCI) at least 6 months post SCI
  • Capable of providing informed consent and reporting age, gender, and neurological condition
  • Neurologically stable (\>6 months post-SCI) and can wear the device and the sensors, provide written informed consent, and follow instruction

You may not qualify if:

  • Participants should not experience another neurological disorder except their primary diagnosed neurological condition (spinal cord injury)
  • Participants should not be pregnant
  • Participants should weigh less than 300 lbs
  • Participants should not have experienced signs of hip/knee pain during the past 2-3 weeks that limits mobility (i.e., reaching, walking, lifting, etc.)
  • Participants should be recovered from any previous surgical interventions, joint injuries, muscle strain, or extreme muscle soreness following surgery
  • Participants should not take medications known to affect bone metabolism, muscle strength or cardiovascular performance or have any ailments causing high fever, high blood pressure, or high heart rate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Syracuse VA Medical Center, Syracuse, NY

Syracuse, New York, 13210-2716, United States

RECRUITING

MeSH Terms

Conditions

Muscle SpasticityMovement DisordersSpinal Cord Injuries

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCentral Nervous System DiseasesSpinal Cord DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Steven W Brose

    Syracuse VA Medical Center, Syracuse, NY

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All participants will be interfered with with a wearable robotic exoskeleton.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2023

First Posted

July 3, 2023

Study Start

February 9, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

February 23, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations